Molecular Basis of Na, K–ATPase Regulation of Diseases: Hormone and FXYD2 Interactions DOI Open Access
Bárbara Fernandes Cordeiro, Carlos Frederico Leite Fontes, José Roberto Meyer‐Fernandes

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(24), P. 13398 - 13398

Published: Dec. 13, 2024

The Na, K–ATPase generates an asymmetric ion gradient that supports multiple cellular functions, including the control of volume, neuronal excitability, secondary ionic transport, and movement molecules like amino acids glucose. intracellular extracellular levels Na+ K+ ions are classical local regulators enzyme’s activity. Additionally, regulation is a complex process occurs at levels, encompassing its total content, subcellular distribution, intrinsic In this context, enzyme serves as regulatory target for hormones, either through direct actions or via signaling cascades triggered by hormone receptors. Notably, FXYDs small transmembrane proteins serve intermediaries linking hormonal to enzymatic various levels. Specifically, members FXYD family, particularly FXYD1 FXYD2, undergo phosphorylation kinases activated receptor signaling, which subsequently influences their modulation This review describes effects cardiotonic steroid hormones such angiotensin II, dopamine, insulin, catecholamines on K–ATPase. Furthermore, highlights implications in diseases hypertension, renal hypomagnesemia, cancer.

Language: Английский

Mechanism of Metal Complexes in Alzheimer’s Disease DOI Open Access

Yi LIU,

Jiaying Ma,

Qianling Zhang

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(22), P. 11873 - 11873

Published: Nov. 5, 2024

Alzheimer's disease (AD) is a kind of neurodegenerative diseases characterized by beta-amyloid deposition and neurofibrillary tangles also the main cause dementia. According to statistics, incidence AD constantly increasing, bringing great burden individuals society. Nonetheless, there no cure for AD, available drugs are very limited apart from cholinesterase inhibitors N-Methyl-D-aspartic acid (NMDA) antagonists, which merely alleviate symptoms without delaying progression disease. Therefore, an urgent need develop medicine that can delay or it. In recent years, increasing evidence suggests metal complexes have enormous potential treat through inhibiting aggregation cytotoxicity Aβ, interfering with congregation hyperphosphorylation tau, regulating dysfunctional synaptic unbalanced neurotransmitters, etc. this review, we summarize current their mechanisms action treating including ruthenium, platinum, zinc, vanadium, copper, magnesium, other complexes.

Language: Английский

Citations

1

Drug Repurposing for Cancer Treatment: A Comprehensive Review DOI Open Access
Abdulaziz H. Al Khzem, Mohamed S. Gomaa, Mansour S. Alturki

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(22), P. 12441 - 12441

Published: Nov. 19, 2024

Cancer ranks among the primary contributors to global mortality. In 2022, incidence of new cancer cases reached about 20 million, while number cancer-related fatalities 9.7 million. Saudi Arabia, there were 13,399 deaths caused by and 28,113 newly diagnosed cancer. Drug repurposing is a drug discovery strategy that has gained special attention implementation enhance process development due its time- money-saving effect. It involves repositioning existing medications clinical applications. treatment therapeutic area where shown most prominent impact. This review presents compilation have been repurposed for various types cancers. describes initial pharmacological classes drugs their applications mechanisms action in treatment. The reports on from successfully treatment, including approved ones those trials preclinical development. stratifies based anticancer repurpose as multi-type, type-specific, mechanism-directed, according classes. also reflects future potential novel therapies.

Language: Английский

Citations

1

Ascorbic Acid in Vanadium Biochemistry, Pharmacology and Detoxification DOI
Enrique J. Baran

New Journal of Chemistry, Journal Year: 2024, Volume and Issue: 48(45), P. 19017 - 19024

Published: Jan. 1, 2024

The most important aspects of the chemistry and structure l -ascorbic acid (vitamin C) will be presented.

Language: Английский

Citations

0

Redox-active polyoxovanadates as cofactors in the development of functional protein assemblies DOI
David E. Salazar Marcano,

Jieh-Jang Chen,

Mhamad Aly Moussawi

et al.

Journal of Inorganic Biochemistry, Journal Year: 2024, Volume and Issue: 260, P. 112687 - 112687

Published: Aug. 2, 2024

Language: Английский

Citations

0

The Role of Vanadium in Metallodrugs Design and Its Interactive Profile with Protein Targets DOI Creative Commons
Otávio Augusto Chaves, Francisco Mainardi Martins, Carlos Serpa

et al.

Future Pharmacology, Journal Year: 2024, Volume and Issue: 4(4), P. 743 - 774

Published: Oct. 24, 2024

Metallodrugs represent a critical area of medicinal chemistry with the potential to address wide range diseases. Their design requires multidisciplinary approach, combining principles inorganic chemistry, pharmacology, and molecular biology create effective safe therapeutic agents. Vanadium, element fifth group first transition series (3d metals), has been already detected as crucial species in biological action some enzymes, e.g., nitrogenases chloroperoxidase; furthermore, vanadium-based compounds have recently described physiologically stable behavior, having anticancer, antidiabetic (insulin-mimicking), antiprotozoal, antibacterial, antiviral, inhibition neurodegenerative disease properties. Since binding metallodrugs serum albumin influences distribution, stability, toxicity (intended off-target interactions), overall pharmacological properties, biophysical characterization between is one hot topics pharmacology. Overall, since vanadium complexes offer new possibilities for novel metallodrugs, this review summarized up-to-date aspects, highlighting proteins main targets based on metal.

Language: Английский

Citations

0

Interaction of VVO2 − Hydrazonates with lysozyme DOI Creative Commons
Maddalena Paolillo, Giarita Ferraro, Gurunath Sahu

et al.

Journal of Inorganic Biochemistry, Journal Year: 2024, Volume and Issue: 264, P. 112787 - 112787

Published: Nov. 29, 2024

Language: Английский

Citations

0

Molecular Basis of Na, K–ATPase Regulation of Diseases: Hormone and FXYD2 Interactions DOI Open Access
Bárbara Fernandes Cordeiro, Carlos Frederico Leite Fontes, José Roberto Meyer‐Fernandes

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(24), P. 13398 - 13398

Published: Dec. 13, 2024

The Na, K–ATPase generates an asymmetric ion gradient that supports multiple cellular functions, including the control of volume, neuronal excitability, secondary ionic transport, and movement molecules like amino acids glucose. intracellular extracellular levels Na+ K+ ions are classical local regulators enzyme’s activity. Additionally, regulation is a complex process occurs at levels, encompassing its total content, subcellular distribution, intrinsic In this context, enzyme serves as regulatory target for hormones, either through direct actions or via signaling cascades triggered by hormone receptors. Notably, FXYDs small transmembrane proteins serve intermediaries linking hormonal to enzymatic various levels. Specifically, members FXYD family, particularly FXYD1 FXYD2, undergo phosphorylation kinases activated receptor signaling, which subsequently influences their modulation This review describes effects cardiotonic steroid hormones such angiotensin II, dopamine, insulin, catecholamines on K–ATPase. Furthermore, highlights implications in diseases hypertension, renal hypomagnesemia, cancer.

Language: Английский

Citations

0